tiprankstipranks
Advertisement
Advertisement

KPRX Stock Latest News

Kiora Pharmaceuticals Shareholders Approve Expanded Equity Incentive Plan
Company AnnouncementsKiora Pharmaceuticals Shareholders Approve Expanded Equity Incentive Plan
3d ago
8K
KPRX
Kiora Pharmaceuticals files to sell 11.8M shares of common stock for holders
PremiumThe Fly
Kiora Pharmaceuticals files to sell 11.8M shares of common stock for holders
26d ago
KPRX
KPRX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
KPRX Earnings this Week: How Will it Perform?
1M ago
KPRX
Strategic Financing and Differentiated KIO‑301 Pipeline Underpin Buy Rating on Kiora Pharmaceuticals (KPRX)
PremiumRatings
Strategic Financing and Differentiated KIO‑301 Pipeline Underpin Buy Rating on Kiora Pharmaceuticals (KPRX)
2M ago
KPRX
Kiora Pharmaceuticals Announces $5 Million Private Placement Financing
PremiumCompany Announcements
Kiora Pharmaceuticals Announces $5 Million Private Placement Financing
2M ago
8K
KPRX
Kiora Pharmaceuticals Announces Chief Development Officer Resignation
PremiumCompany AnnouncementsKiora Pharmaceuticals Announces Chief Development Officer Resignation
2M ago
8K
KPRX
Clinical and Market Validation of Kiora’s Lead Programs Underpin Buy Rating and $12 Price Target
Premium
Ratings
Clinical and Market Validation of Kiora’s Lead Programs Underpin Buy Rating and $12 Price Target
4M ago
KPRX
Kiora Pharmaceuticals: Strong Financial Position and Promising Clinical Developments Drive Buy Rating
Premium
Ratings
Kiora Pharmaceuticals: Strong Financial Position and Promising Clinical Developments Drive Buy Rating
7M ago
KPRX
Kiora Pharmaceuticals Reports Improved Financial Performance
PremiumCompany Announcements
Kiora Pharmaceuticals Reports Improved Financial Performance
7M ago
KPRX
Kiora Pharmaceuticals Advances Phase II Study for Retinitis Pigmentosa Treatment
PremiumCompany Announcements
Kiora Pharmaceuticals Advances Phase II Study for Retinitis Pigmentosa Treatment
8M ago
KPRX
Kiora Pharmaceuticals Advances Promising Eye Treatment with KIO-301 Study
PremiumCompany Announcements
Kiora Pharmaceuticals Advances Promising Eye Treatment with KIO-301 Study
8M ago
KPRX
Kiora Pharmaceuticals’ KIO-104: A Promising Treatment for Macular Edema?
PremiumCompany Announcements
Kiora Pharmaceuticals’ KIO-104: A Promising Treatment for Macular Edema?
8M ago
KPRX
Kiora Pharmaceuticals files $100M mixed securities shelf
PremiumThe FlyKiora Pharmaceuticals files $100M mixed securities shelf
9M ago
KPRX
Kiora Pharmaceuticals Highlights at Ophthalmology Conference
Premium
Company Announcements
Kiora Pharmaceuticals Highlights at Ophthalmology Conference
10M ago
8K
KPRX
Promising Developments and Strategic Partnerships Drive Buy Rating for Kiora Pharmaceuticals
Premium
Ratings
Promising Developments and Strategic Partnerships Drive Buy Rating for Kiora Pharmaceuticals
10M ago
KPRX
Kiora Pharmaceuticals Advances Retinal Disease Pipeline
PremiumCompany Announcements
Kiora Pharmaceuticals Advances Retinal Disease Pipeline
10M ago
KPRX
Positive Outlook for Kiora Pharmaceuticals: Buy Rating Affirmed Amid Promising Developments and Strategic Initiatives
PremiumRatings
Positive Outlook for Kiora Pharmaceuticals: Buy Rating Affirmed Amid Promising Developments and Strategic Initiatives
11M ago
KPRX
Kiora Pharmaceuticals granted new patent for KIO-104, says H.C. Wainwright
PremiumThe Fly
Kiora Pharmaceuticals granted new patent for KIO-104, says H.C. Wainwright
11M ago
KPRX
Kiora Pharmaceuticals Holds Annual Meeting, Elects Directors
PremiumCompany Announcements
Kiora Pharmaceuticals Holds Annual Meeting, Elects Directors
1y ago
8K
KPRX
Kiora Pharmaceuticals: Strategic Partnerships and Promising Financial Prospects Drive Buy Rating
PremiumRatingsKiora Pharmaceuticals: Strategic Partnerships and Promising Financial Prospects Drive Buy Rating
1y ago
KPRX
Kiora Pharmaceuticals Secures Exclusive Option Agreement with Senju
Premium
Company Announcements
Kiora Pharmaceuticals Secures Exclusive Option Agreement with Senju
1y ago
8K
KPRX
Kiora Pharmaceuticals Reports Q1 2025 Financial Results
Premium
Company Announcements
Kiora Pharmaceuticals Reports Q1 2025 Financial Results
1y ago
KPRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >